Immunologic uniqueness of the genital tract: challenge for vaccine development.
about
Enhancing oral vaccine potency by targeting intestinal M cellsHow do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?Antisperm contraceptive vaccines: where we are and where we are going?Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design.Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infectionHumoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Formulation and characterization of nanoemulsion intranasal adjuvants: effects of surfactant composition on mucoadhesion and immunogenicity.Vaginal delivery of the recombinant HIV-1 clade-C trimeric gp140 envelope protein CN54gp140 within novel rheologically structured vehicles elicits specific immune responsesRectal administration of a chlamydial subunit vaccine protects against genital infection and upper reproductive tract pathology in mice.Mucosal correlates of protection in HIV-1-exposed sero-negative persons.Both systemic and mucosal LCMV immunization generate robust viral-specific IgG in mucosal secretions, but elicit poor LCMV-specific IgA.Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.Genital Chlamydia trachomatis: an update.Vaccine delivery by polymeric vehicles in the mouse reproductive tract induces sustained local and systemic immunityInduction of immune memory by a multisubunit chlamydial vaccineProtein-coated nanoparticles are internalized by the epithelial cells of the female reproductive tract and induce systemic and mucosal immune responses.Methods for evaluation of humoral immune responses in human genital tract secretions.Transcriptional fingerprints of antigen-presenting cell subsets in the human vaginal mucosa and skin reflect tissue-specific immune microenvironments.Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model.Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate modelMolecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.Vaginal immunization to elicit primary T-cell activation and dissemination.Chlamydia trachomatis vaccine research through the years.Scarcity or absence of humoral immune responses in the plasma and cervicovaginal lavage fluids of heavily HIV-1-exposed but persistently seronegative women.Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition studySystemic and mucosal differences in HIV burden, immune, and therapeutic responsesIn vivo distribution of surface-modified PLGA nanoparticles following intravaginal deliveryPhenotype and function of regulatory T cells in the genital tract.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeIntranasal delivery of vaccines against HIV.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Delivery of DNA HIV-1 vaccine to the liver induces high and long-lasting humoral immune responsesFunctional diversity of human vaginal APC subsets in directing T-cell responses.Cervical leukocytes and spontaneous preterm birth.Dendritic cells and vaccine design for sexually-transmitted diseases.Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected womenImplication of nanoparticles/microparticles in mucosal vaccine delivery.Stone age diseases and modern AIDS.HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.The reproductive cycle is a pathogenic determinant during gonococcal pelvic inflammatory disease in mice.
P2860
Q21089613-D8396EB2-FB6C-4C0F-89B9-A3A2CCF3329DQ25257230-F1220BA9-08BB-4C03-868C-1D5F34AB022EQ28235213-A6A371CA-D82C-4267-8E5B-6CCFEA0B71ABQ30375160-A43E313B-FDD5-42DE-8292-8050DB8C4EDAQ33575368-8B45C0A2-1D08-4E15-B329-4E0E4CD3D5DFQ33624872-C44D2757-8AC2-454F-84BB-0E9826F0E7A4Q33650861-3E521858-8D0A-4A7A-A77C-91836A2E27ABQ33665816-F3F43376-8F44-4767-8866-8281E126C3B4Q33751862-44D63C60-B685-4E19-9EAB-8944C8C66724Q33911540-1392B92D-287F-40C9-91EF-EA3EC47FA5DCQ34296797-4CC50EFC-A4D2-43F2-A462-A262B51840E4Q34339797-FBD5A4CC-B4B0-4E83-B8B7-1227682FBA5FQ34378357-DBC61310-CA02-4ED4-BC9D-575425FE8D34Q34415303-5627AC65-6A6C-4433-A657-EED53C9952C8Q34546923-9DDA6E06-3485-4C5A-A3B0-EA50F17863FDQ34663077-BD1102DF-462D-43F4-A835-49D46F632F4DQ34676467-C634377A-77C3-4027-BC41-65DCD87812E3Q34721358-00589D48-2251-4C2E-81A9-36F166D3D27CQ34739969-A735FB28-4C85-4110-8219-FE1E43DCAD37Q34886221-9979C7BF-EE83-4F3A-83CD-CB55DC3F7301Q34974782-F510A0BE-0B6A-4D8F-B8E3-4B5F64F42A43Q35069383-D81F537E-B57C-40D2-A1D1-1115E537B694Q35071155-121C0983-E93D-49AA-A98B-617B40296759Q35093052-6F179859-4590-4043-8670-7EBBD1CC0521Q35144254-B79C53FF-CD96-4A9D-B112-D517A114C621Q35190200-A4A6CC95-0339-4EA2-8A25-8612244B90D7Q35563449-8AF657F4-623E-41D3-9B99-BCCCF6BDA89FQ35697870-3ED2C1A3-A6F9-474B-987F-CA9BB72CFF83Q35871689-EB5BF121-5E97-4EF2-B845-090DD5BF790BQ36409054-F445F2DF-1F5E-43CF-9DC5-1A629C690A9AQ36555158-D3364002-522D-45A5-9B53-AFF6B6ADE596Q36571388-14E8DC3F-594D-41E6-BD9C-0EB9EB062B40Q36597690-08FD2E11-EB36-438E-B1D9-3C46C6EED015Q36610270-9065F47F-3ADE-4D84-8327-6A953237603DQ36681262-9218F04F-856E-4B12-8DEC-6BFB7B84765FQ36753653-A6759523-5BDE-42A7-ABFF-D13D77C8D0ACQ36837152-DEE44D4C-E8DD-4C62-8A1D-AF357B16A14CQ36865422-383E71F0-9924-4E3D-A1BC-17C03C67E5ECQ36874604-9C6D1A43-0A0B-45F7-BA4C-1964D560CB3FQ37026470-54FE01CA-F34C-4CB0-A45C-8EFE38454B86
P2860
Immunologic uniqueness of the genital tract: challenge for vaccine development.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Immunologic uniqueness of the genital tract: challenge for vaccine development.
@ast
Immunologic uniqueness of the genital tract: challenge for vaccine development.
@en
type
label
Immunologic uniqueness of the genital tract: challenge for vaccine development.
@ast
Immunologic uniqueness of the genital tract: challenge for vaccine development.
@en
prefLabel
Immunologic uniqueness of the genital tract: challenge for vaccine development.
@ast
Immunologic uniqueness of the genital tract: challenge for vaccine development.
@en
P2093
P2860
P1476
Immunologic uniqueness of the genital tract: challenge for vaccine development.
@en
P2093
Jiri Mestecky
Michael W Russell
Zina Moldoveanu
P2860
P304
P356
10.1111/J.1600-0897.2005.00267.X
P577
2005-05-01T00:00:00Z